Is 0030.HK overvalued or undervalued?

0030.HK currently has a P/E ratio of 77.78. Relative to the sector average of 8.60, this suggests the stock may be overvalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy YNBY International Ltd. stock?

YNBY International Ltd. trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 0030.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 0030.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 0030.HK to protect their purchasing power. Because 0030.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 0030.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 0030.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 0030.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks0030.HK

YNBY International Ltd.

HK$0.21-HK$0.01-5.41%

HKSE / HKD

Market cap

HK$2.0B

P/E

77.8

EPS (TTM)

HK$0.00

Dividend yield

0.00%

Beta

-0.15

1Y return

-15.66%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$23M2021

$58M2022

$99M2023

$97M2024

$142M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.02Low
Current ratio2.54
Cash ratio0.86
Net margin0.4%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

0030.HK77.8
Financial Services sector median8.6
S&P 50022.0

Trades about 804% above its sector, the market expects faster growth.

Ratios

PEG0.78
Price to book5.60
EPS (TTM)HK$0.00
Payout ratio0%
FCF yield-5.62%

Range & risk

HK$0.18HK$0.33

Trading in the lower third of its 52-week band

Beta-0.15

Profile

What YNBY International Ltd. actually does

YNBY International Ltd. operates as an investment holding company, conducting business primarily in money lending and the global trade of various goods and commodities across Hong Kong, the People's Republic of China, and international territories. The firm's operations are divided into distinct segments: Money Lending, Trading of Goods and Commodities, and Cannabidiol (CBD) isolate. In its financial services arm, the company offers short-term loans to both private individuals and corporate entities. Its trading activities encompass a diverse portfolio, including refined edible oil, sugar, cosmetics, cannabidiol, and personal care products. Moreover, YNBY International has established a strategic partnership with Alpex Pharma SA to jointly advance the development and commercialization of nutraceuticals. Located in Wan Chai, Hong Kong, the company adopted its current name after previously operating as ABC Communications (Holdings) Limited and subsequently as Ban Loong Holdings Limited, a change that occurred in October 2015.

CEO

Ming Tang

Employees

Headquarters

Hong Kong

Founded

2000-01-04

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 0030.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

0030.HK has a beta of -0.15, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

YNBY International Ltd.